China's NDRC Drafting Plan To Cut Drug Prices By 40 Percent
This article was originally published in PharmAsia News
China's National Development and Reform Commission is drafting a plan to cut drug prices by an average 40 percent, an NDRC official confirmed, adding that the commission has not yet decided whether and when the plan will be implemented
You may also be interested in...
Three-month results of the SPYRAL HTN-OFF MED pivotal trial show renal denervation with Medtronic’s Symplicity Spyral system significantly reduced blood pressure in hypertensive patients not taking anti-hypertensive medications.
Medtronic says that most of the clinical trials it is sponsoring are paused due to the pandemic, which means the completion of its PMA application for the Symplicity Spyral renal denervation system will be delayed.
Germany has ramped up its COVID-19 testing capacity to 260,000 per week, and still has a relatively low death rate from the virus. The country's diagnostics industry says it is ready to play its part “24/7.”